跳至主要内容
临床试验/NCT06140173
NCT06140173Unknown不适用

Randomized Controlled Trial of Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction

Queen Savang Vadhana Memorial Hospital, Thailand0 个研究点目标入组 66 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
66
主要终点
Rate of operative intervention

研究概览

简要总结

Adhesive small bowel obstruction (ASBO) is a condition that is commonly found in patients with history of abdominal surgery. The management for such condition can be controversial. In terms of conservative treatment, recent studies have shown conflicting outcomes on whether water soluble contrast would provide benefit in reducing number of patients needed for surgery. In addition, there are a limited number of literature that investigates the role of low-osmolar contrast in reducing operative need in patients diagnosed with ASBO.

The objective of this study is to compare the operative rate of patient diagnosed with ASBO between patients who were treated with low osmolar water soluble contrast (Iohexol) and patients who were treated traditionally.

详细描述

This study is a randomized, controlled and double-blinded study, where participants who were diagnosed with ASBO will be randomly allocated into two groups:

(i) A contrast group (CG): Patients will be treated conservatively and received Omnipaque (Iohexol) via nasogastric tube

(ii) A traditional group (TG): Patients will be treated conservatively and received sterile water via nasogastric tube

After obtaining informed consent, the patient will be administered with either 100 mL of 350 mg Omnipaque or 100 mL of sterile water via nasogastric tube. The nasogastric tube will be clamped for 1 hour and patient will be positioned with 30 degree head elevation. In the contrast group (CG), surgery is indicated when contrast failed to reach the colon. Failure of conservative treatment is considered when there are no clinical improvements after 48 hours and the patient will then be proceeded for surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are presented with clinical manifestation of small bowel obstruction due to adhesion and require radiological investigations
  • Patients who has history of abdominal surgery over 30 days

排除标准

  • Patients with clinical signs and symptoms of bowel strangulation, ischemia, perforation or peritonitis
  • Patients with clinical signs and symptoms of bowel obstruction from non-adhesive causes, including malignancy, herniation, inflammatory bowel disease, Crohn's disease, and others.
  • Patients who has history of allergy to water soluble contrast agent

结局指标

主要结局

Rate of operative intervention

时间窗: At 72 hour

Patients who developed signs of peritonitis or failed conservative treatment or no clinical improvement after 72 hours will be managed surgically

次要结局

未报告次要终点

研究者

发起方
Queen Savang Vadhana Memorial Hospital, Thailand
申办方类型
Other
责任方
Sponsor

相似试验